Experts Call For Vaccine To Prevent Group B Streptococcus Infection Among Babies

The Guardian: Streptococcus vaccine ‘could prevent over 100,000 baby deaths worldwide’
“More than 100,000 stillbirths and baby deaths worldwide could be prevented by the development of a vaccine against an infection commonly carried by pregnant women, according to a groundbreaking report. The impact of disease caused by group B streptococcus (GBS) has not been properly chronicled before and only in relatively recent years has anyone taken seriously its role in the deaths of babies in the womb as well as in the early days of life. Worldwide, more than 21 million pregnant women carry the bacteria which used to be thought harmless, say researchers from the London School of Hygiene and Tropical Medicine (LSHTM). Today it is recognised as a cause of septicaemia and meningitis in newborns, with potentially deadly effects, and also as a major cause of stillbirths, but vaccines against it are only now in development…” (Boseley, 11/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.